KOSDAQ · Healthcare · ₩165B
₩12,500-2.42%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 3.4% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“치료제 개발 성과를 바탕으로 판매 준비가 본격화됐어요.”
In the company's words · 2026 2분기 filing